IHS Chemical Week

EnviroTech :: R&D

Dowpharma Sells Pfenex Test Kits

2:02 PM MDT | July 25, 2007 | Chemical Week Editorial Staff

Dowpharma says that biotechnology firm Cygnus Technologies (Southport, NC) has begun selling testing kits for Dowpharma’s biopharma protein expression system, dubbed Pfenex, based on Pseudomonas fluorescens bacteria. “This new kit will enable users of Dowpharma Pfenex Expression Technology to routinely test their products for the presence of host cell protein with a fully validated method,” says Charles Squires, R&D director/Dowpharma. The company says it developed Pfenex for biologics manufacturers to optimize the expression of target...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa